These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10051814)

  • 1. [Prioritization problems in the prevention of ischemic heart disease].
    Hansen JF; Videbaek J
    Ugeskr Laeger; 1999 Feb; 161(7):973-4. PubMed ID: 10051814
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of ischemic heart disease--evidence-based].
    Heebøll-Nielsen NC
    Ugeskr Laeger; 2000 Sep; 162(37):4941-3. PubMed ID: 11002746
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical guidelines and prevention of ischemic heart disease in family practice].
    Lauritzen T; Christensen B
    Ugeskr Laeger; 1998 Dec; 160(50):7239. PubMed ID: 9859719
    [No Abstract]   [Full Text] [Related]  

  • 4. [DSAM's clinical guidelines for prevention of ischemic heart disease 2007].
    Ibsen H
    Ugeskr Laeger; 2007 May; 169(21):2039; author reply 2041. PubMed ID: 17571319
    [No Abstract]   [Full Text] [Related]  

  • 5. A multifaceted intervention according to the Audit Project Odense method improved secondary prevention of ischemic heart disease: a randomised controlled trial.
    Søndergaard J; Hansen DG; Aarslev P; Munck AP
    Fam Pract; 2006 Apr; 23(2):198-202. PubMed ID: 16243954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the effect of prevention of ischaemic heart disease.
    Brønnum-Hansen H
    Scand J Public Health; 2002; 30(1):5-11. PubMed ID: 11928834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease after discharge in 1997-98 and 1999-2000].
    Jankowski P; Kawecka-Jaszcz K; Pajak A; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):142-6. PubMed ID: 14575014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comments on Brønnum-Hansen: predicting the effect of prevention of ischaemic heart disease.
    Andersen LB; Saltin B
    Scand J Public Health; 2002; 30(4):315-6; author reply 317-8. PubMed ID: 12680510
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alcohol as prevention of ischemic heart and cerebral disease?].
    Mikkelsen B
    Ugeskr Laeger; 1999 Oct; 161(41):5696-7. PubMed ID: 10565244
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prevention of patients with documented ischemic heart disease].
    Haghfelt TH
    Ugeskr Laeger; 1999 Jun; 161(24):3630. PubMed ID: 10507946
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diet and secondary prevention of ischemic heart disease].
    Stender S; Astrup AV; Dyerberg J; Faergeman O; Godtfredsen J; Marckmann P; Viggers L; Lind EM
    Ugeskr Laeger; 1997 Feb; 159(8):1119-21. PubMed ID: 9072862
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of ischemic heart disease in adults. Joint recommendations of Czech professional societies].
    Czech Cardiology Society, Czech Atherosclerosis Society, Czech Hypertension Society, and the following sections of the J.E. Purkyne Czech Medical Society: Czech Internal Medicine Society, Czech Diabetology Society, General Practice Society, Czech Angiology Society, Czech Society of Clinical Biochemistry and Czech Bariatric Society
    Vnitr Lek; 2000 Dec; 46 Suppl 1():14-22. PubMed ID: 11702523
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary prophylaxis in general practice for patients with ischemic heart disease].
    Hamm LR; Bjerrum L; Aarslev PJ; Munck AP; Vach K; Kragstrup J
    Ugeskr Laeger; 2002 Jul; 164(27):3534-7. PubMed ID: 12116682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disturbances in mitochondrial biosynthesis of acetyl-CoA and their role in the prevention of ischemic heart disease].
    Burchardt P; Wiktorowicz K; Goździcka-Józefiak A; Parucki R; Wysocki H
    Kardiol Pol; 2008 Nov; 66(11):1215-20. PubMed ID: 19105101
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of new "recommendations" for treatment of arterial hypertension and prevention of ischemic heart disease in general clinical practice].
    Horký K
    Vnitr Lek; 2000 Dec; 46 Suppl 1():3-4. PubMed ID: 11702524
    [No Abstract]   [Full Text] [Related]  

  • 16. Secondary prevention of ischemic heart disease: closing the gap.
    Fainaru M
    Isr Med Assoc J; 2005 Jun; 7(6):400-1. PubMed ID: 15984387
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of recurrence of ischemic heart disease: discussion].
    Matsuoka H; Ishimura T; Saito T; Hiromori K; Yanbe Y
    Nihon Naika Gakkai Zasshi; 1997 Feb; 86(2):283-300. PubMed ID: 9139067
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cracovian program for secondary prevention of ischemic heart disease. Secondary prevention of ischemic heart disease during hospitalization in 1996-97 and 1998-99].
    Pajak A; Kawecka-Jaszcz K; Jankowski P; Bilo G; Dubiel JS; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2003; 60(3):136-41. PubMed ID: 14575013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and primary prevention of ischemic heart disease in women.
    Abramson B
    Can J Cardiol; 2001 Nov; 17 Suppl D():24D-31D. PubMed ID: 11726993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.